Literature DB >> 11211116

GABA(C) receptors in neuroendocrine gut cells: a new GABA-binding site in the gut.

A Jansen1, M Hoepfner, K H Herzig, E O Riecken, H Scherübl.   

Abstract

Although GABA(C) receptors play a crucial role in the mammalian central nervous system, their functional expression in peripheral tissues has not yet been studied. Using the gut neuroendocrine tumor cell line STC-1 as a model, we provide first evidence for the functional expression of GABA(C) receptors in the gut: mRNAs of the GABA(C) receptor subunits rho1 and rho2 were detected in STC-1 cells by reverse transcription polymerase chain reaction (RT-PCR). Applying anti-rho-antibodies, specific immunostaining for GABA(C) receptors was observed. For functional characterization, the effects of GABA(C) receptor activation on [Ca2+]i and hormone secretion were studied. The selective GABA(C) receptor agonist cis-4-aminocrotonic acid (CACA) induced dose-dependent increases both of [Ca2+]i and of hormone (cholecystokinin) secretion. The stimulatory effects of CACA were antagonized by the GABA(C) receptor blockers (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid (TPMPA) and 3-aminopropyl(methyl)phosphinic acid (3-APMPA). These results demonstrate that GABA(C) receptors play an important role in neuroendocrine gastrointestinal secretion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11211116     DOI: 10.1007/s004240000412

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  10 in total

1.  Ionotropic GABA receptor expression in the lung during development.

Authors:  Nili Jin; Yujie Guo; Peng Sun; Anna Bell; Narendranath Reddy Chintagari; Manoj Bhaskaran; Kimberly Rains; Pradyumna Baviskar; Zhongming Chen; Tingting Weng; Lin Liu
Journal:  Gene Expr Patterns       Date:  2008-05-03       Impact factor: 1.224

Review 2.  GABA-ρ receptors: distinctive functions and molecular pharmacology.

Authors:  Moawiah M Naffaa; Sandy Hung; Mary Chebib; Graham A R Johnston; Jane R Hanrahan
Journal:  Br J Pharmacol       Date:  2017-04-12       Impact factor: 8.739

3.  Tax1-binding protein 1 is expressed in the retina and interacts with the GABA(C) receptor rho1 subunit.

Authors:  Melanie Ulrich; Silke Seeber; Cord-Michael Becker; Ralf Enz
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

4.  The neurotransmitters glycine and GABA stimulate glucagon-like peptide-1 release from the GLUTag cell line.

Authors:  A Gameiro; F Reimann; A M Habib; D O'Malley; L Williams; A K Simpson; F M Gribble
Journal:  J Physiol       Date:  2005-10-13       Impact factor: 5.182

Review 5.  Unsaturated Analogues of the Neurotransmitter GABA: trans-4-Aminocrotonic, cis-4-Aminocrotonic and 4-Aminotetrolic Acids.

Authors:  Graham A R Johnston
Journal:  Neurochem Res       Date:  2015-05-27       Impact factor: 3.996

6.  Guanidino acids act as rho1 GABA(C) receptor antagonists.

Authors:  Mary Chebib; Navnath Gavande; Kit Yee Wong; Anna Park; Isabella Premoli; Kenneth N Mewett; Robin D Allan; Rujee K Duke; Graham A R Johnston; Jane R Hanrahan
Journal:  Neurochem Res       Date:  2009-04-23       Impact factor: 3.996

7.  Resveratrol Inhibits GABAC ρ Receptor-Mediated Ion Currents Expressed in Xenopus Oocytes.

Authors:  Byung-Hwan Lee; Sun-Hye Choi; Sung-Hee Hwang; Hyeon-Joong Kim; Joon-Hee Lee; Seung-Yeol Nah
Journal:  Korean J Physiol Pharmacol       Date:  2013-04-10       Impact factor: 2.016

8.  An Update on GABAρ Receptors.

Authors:  Gustavo Martínez-Delgado; Argel Estrada-Mondragón; Ricardo Miledi; Ataúlfo Martínez-Torres
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

9.  Identification of GABA receptors in chick cornea.

Authors:  Zhen-Ying Cheng; Mary Chebib; Katrina L Schmid
Journal:  Mol Vis       Date:  2012-05-01       Impact factor: 2.367

10.  A novel approach in the treatment of neuroendocrine gastrointestinal tumors: additive antiproliferative effects of interferon-gamma and meta-iodobenzylguanidine.

Authors:  Michael Höpfner; Andreas P Sutter; Alexander Huether; Gudrun Ahnert-Hilger; Hans Scherübl
Journal:  BMC Cancer       Date:  2004-05-21       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.